Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the best hot stocks to invest in.
Monopar Therapeutics (MNPR)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 667,207 | $61,776,696 | 0.54% | |
| 2. | Deerfield Management James E. Flynn | 323,745 | $29,975,550 | 0.31% | |
| 3. | Saturn V Capital Management Xiaoying Tian | 311,976 | $28,885,858 | -10% | 4.14% |
| 4. | Siren L.L.C. Raymond Debbane | 270,118 | $25,010,226 | 0.51% | |
| 5. | ADAR1 Capital Management Daniel Schneeberger | 217,595 | $20,147,121 | -18% | 0.92% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.95 | 1,500 | $104,925.00 | 1,500 | 2025-12-26 | Filing | |
| $16.25 | 1,550 | $25,187.50 | 1,550 | 2024-10-28 | Filing | |
| $0.74 | 20,508 | $15,253.85 | 186,132 | 2024-06-20 | Filing | |
| $0.86 | 12,000 | $10,320.00 | 165,624 | 2024-06-18 | Filing | |
| $0.90 | 12,000 | $10,798.80 | 153,624 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $79.67 | 799 | $63,656.33 | 5,173 | 2026-10-01 | Filing | |
| $78.82 | 2,970 | $234,095.40 | 5,972 | 2026-10-01 | Filing | |
| $78.09 | 4,631 | $361,634.79 | 8,942 | 2026-10-01 | Filing | |
| $89.79 | 600 | $53,874.00 | 99,267 | 2026-09-24 | Filing | |
| $88.97 | 8,368 | $744,500.96 | 99,867 | 2026-09-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 39 | $3,107 | 0% | |
| 2. | 24 | $1,912 | 0% | |
| 3. | 3 | $239 | 0% |
News See All
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Chardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives Buy
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds.
10 Unstoppable Stocks to Buy According to Hedge Funds
In this article, we will discuss the 10 Unstoppable Stocks to Buy According to Hedge Funds.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
5 Best Rising Penny Stocks To Buy
This article presents an overview of the 5 Best Rising Penny Stocks To Buy. For a detailed overview of such stocks, read our article, 12 Best Rising Penny Stocks To Buy. 5.
5 Hot Penny Stock On the Move
This article presents an overview of the 5 Hot Penny Stock On the Move. For a detailed overview of such stocks, read our article, 15 Hot Penny Stock On the Move. 5.
Hedge Fund Resource Center